CBIS News 12/27/2016 - 0.0616
Post# of 273249
Posted On: 12/27/2016 1:05:41 PM
Cannabis Science, Inc. $CBIS News
Last updated 12/27/2016 - 0.0616
BCSC Cease Trade Order
Jun 04, 2015
OTC Disclosure & News Service
British Columbia, Canada - Citation: 2015 BCSECCOM 217
Cease Trade Order
Cannabis Science, Inc.
Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
¶ 1 Cannabis Science, Inc. (Cannabis Science) is a Nevada corporation with securities quoted
on the OTC Pink marketplace of the OTC Markets. Cannabis Science is an OTC
reporting issuer under Multilateral Instrument 51-105 Issuers Quoted in the U.S. Overthe-
Counter Markets as its business has been directed or administered in or from British
Columbia since November 5, 2014.
¶ 2 Cannabis Science has failed to file any of the records required under the Act and
regulations as an OTC reporting issuer (the required records).
¶ 3 Under section 164(1) of the Act, the Executive Director orders that all persons cease
trading in Cannabis Science’s securities until:
1. Cannabis Science files the required records completed in accordance with the Act and
regulations, and
2. the Executive Director revokes this order.
¶ 4 June 4, 2015
Andrew S. Richardson, CPA, CA
Chief of Compliance
Corporate Finance
Copyright © 2015 OTC Markets. All Rights Reserved
Last updated 12/27/2016 - 0.0616
BCSC Cease Trade Order
Jun 04, 2015
OTC Disclosure & News Service
British Columbia, Canada - Citation: 2015 BCSECCOM 217
Cease Trade Order
Cannabis Science, Inc.
Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
¶ 1 Cannabis Science, Inc. (Cannabis Science) is a Nevada corporation with securities quoted
on the OTC Pink marketplace of the OTC Markets. Cannabis Science is an OTC
reporting issuer under Multilateral Instrument 51-105 Issuers Quoted in the U.S. Overthe-
Counter Markets as its business has been directed or administered in or from British
Columbia since November 5, 2014.
¶ 2 Cannabis Science has failed to file any of the records required under the Act and
regulations as an OTC reporting issuer (the required records).
¶ 3 Under section 164(1) of the Act, the Executive Director orders that all persons cease
trading in Cannabis Science’s securities until:
1. Cannabis Science files the required records completed in accordance with the Act and
regulations, and
2. the Executive Director revokes this order.
¶ 4 June 4, 2015
Andrew S. Richardson, CPA, CA
Chief of Compliance
Corporate Finance
Copyright © 2015 OTC Markets. All Rights Reserved
(0)
(0)Scroll down for more posts ▼